Injectable Lidocaine Recalled Due to Lack of Sterility Assurance
Central Admixture Pharmacy Services is recalling lidocaine 2% injectables due to inability to assure sterility. Approximately 1,992 syringes distributed nationwide are affected.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a sterile injectable medication where the manufacturer cannot assure sterility. While no illnesses or injuries have been reported, this represents a risk-of-harm product where sterile manufacturing integrity is compromised.
Plain-English summary
Central Admixture Pharmacy Services Inc is recalling lidocaine 2% (100 mg/5 mL) injectable syringes due to a lack of assurance of sterility. The recall affects approximately 1,992 syringes distributed nationwide.
The recalled product is lidocaine 2%, 20 mg/mL supplied in 5 mL syringes, manufactured by Central Admixture Pharmacy Services Inc (NDC 71286-6006-1). The affected lots are 17-275788 (expiring 10/10/2023), 17-275872 (expiring 10/11/2023), 17-275922 (expiring 10/12/2023), and 17-275972 and 17-275973 (both expiring 10/15/2023).
Sterile injectable medications must maintain sterility to prevent harm. The manufacturer was unable to provide assurance that these lots met sterility requirements.
Persons who have received or are using this product should discontinue use and contact the manufacturer or the FDA for guidance on return or disposal of unused product.
The recalled product
- Product
- lidocaine 2%, 100 mg/5 mL, (20 mg/mL), 5 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6006-1
- Manufacturer
- Central Admixture Pharmacy Services Inc
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lot: 17-275788
- Exp. 10/10/2023
- 17-275872
- Exp. 10/11/2023
- 17-275922
- Exp. 10/12/2023
- 17-275972
- 17-275973
- Exp. 10/15/2023.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 32 recalled by Central Admixture Pharmacy Services Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 32 products in this recall →Related recalls
Same manufacturer · Central Admixture Pharmacy Services Inc
See all →- ModeratePediatric TPN Bags Recalled for Incorrect Formulation
FDA (Drugs) · 2026-08-12
- SeverePediatric Total Parenteral Nutrition Bag Recalled for Incorrect Formulation
FDA (Drugs) · 2026-07-01
- SevereInjectable Phenylephrine Solution Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2025-03-19
- HighMidazolam Injectable Solution Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2023-10-11
- HighHYDROmorphone Injectable Syringes Recalled Over Sterility Assurance Issues
FDA (Drugs) · 2023-10-11
Same hazard · contamination risk
See all →- HighIntramedullary Bone Saw Blade Assembly Recall for Packaging Damage
FDA (Devices) · 2026-08-12
- SevereMedical Convenience Kits Recalled Over Lidocaine Injection Supplier Quality Issues
FDA (Devices) · 2026-08-05
- ModeratePhantom Hindfoot Guide Rods Recalled Due to Sterile Barrier Breaches
FDA (Devices) · 2026-07-29
- HighOlympus Glass Body for 194 Ellik Evacuator Model 190A Sterilization Recall
FDA (Devices) · 2026-07-22
- HighVasoview Hemopro 2 Endoscopic Vessel Harvesting System Recall
FDA (Devices) · 2026-07-22